Plant-based Adjuvant in Vaccine Immunogenicity: A Review

Author(s): P.K. Lakshmi, Shweta Kumar, Sulakshhna Pawar, M.S. Sudheesh, Rajesh Singh Pawar*.

Journal Name: Current Traditional Medicine

Volume 4 , Issue 3 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: The problem of poor immunogenicity of new generation vaccines has generated the need for more effective and safe adjuvants for inducing a seroprotective immune response.

Objective and Method: The plant-based immunoadjuvants have the potential to promote an optimized immune response and are promising candidate adjuvants for novel vaccine development. There are many natural compounds, which exhibit vaccine adjuvant activity. However, safety and hemolytic toxicity remain a problem. Research in the last four decades shows that plant extracts can be screened for isolating the least toxic adjuvant. Plant-based adjuvants with their superior immunostimulatory property could provide us with an effective alternative to conventional adjuvants.

Conclusion: The present paper enumerates the plant-based immunoadjuvant which has shown remarkable immunostimulatory properties.

Keywords: Haemolytic, immunoadjuvant, ovalbumin, polysaccharide, saponins, splenocyte.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 4
ISSUE: 3
Year: 2018
Page: [215 - 236]
Pages: 22
DOI: 10.2174/2215083804666180830142648
Price: $58

Article Metrics

PDF: 6